With the development of medical imaging, the understanding of the nervous system has become more in-depth and has gradually expanded from anatomical structure imaging to metabolic imaging. Chemical exchange saturation transfer imaging can detect a variety of neural endogenous metabolites, including glutamate, glucose, and amide proton. In addition, the detection of the glymphatic system promises to reveal more metabolic mechanisms of neurological disorders. These technologies can provide quantitative and refined details for neuroimaging and improve the detection, screening, classification, and prognosis of diseases.
This Research Topic aims to highlight recent progress and trends in the imaging of
neurometabolism and promote the development of radiological diagnosis in neurological diseases. We seek to provide a platform to disseminate these technologies, which can be experimented in the whole spectrum of neurological disorders. Research using healthy volunteers for technological improvement is also welcome. Moreover, the combination of these imaging modalities to yield complementary information is encouraged to offer synergistic advantages. Finally, we invite comprehensive in-depth reviews of these techniques to help researchers in related fields understand these imaging capabilities and limitations.
Topics of interest include, but are not limited to, the following:
• Magnetic resonance spectrum (MRS) to quantify metabolites
• Chemical exchange saturation transfer (CEST)
• Imaging of glymphatic system
• Multimodality imaging of the brain
• Positron emission tomography (PET) imaging
With the development of medical imaging, the understanding of the nervous system has become more in-depth and has gradually expanded from anatomical structure imaging to metabolic imaging. Chemical exchange saturation transfer imaging can detect a variety of neural endogenous metabolites, including glutamate, glucose, and amide proton. In addition, the detection of the glymphatic system promises to reveal more metabolic mechanisms of neurological disorders. These technologies can provide quantitative and refined details for neuroimaging and improve the detection, screening, classification, and prognosis of diseases.
This Research Topic aims to highlight recent progress and trends in the imaging of
neurometabolism and promote the development of radiological diagnosis in neurological diseases. We seek to provide a platform to disseminate these technologies, which can be experimented in the whole spectrum of neurological disorders. Research using healthy volunteers for technological improvement is also welcome. Moreover, the combination of these imaging modalities to yield complementary information is encouraged to offer synergistic advantages. Finally, we invite comprehensive in-depth reviews of these techniques to help researchers in related fields understand these imaging capabilities and limitations.
Topics of interest include, but are not limited to, the following:
• Magnetic resonance spectrum (MRS) to quantify metabolites
• Chemical exchange saturation transfer (CEST)
• Imaging of glymphatic system
• Multimodality imaging of the brain
• Positron emission tomography (PET) imaging